Home » Stocks » BLU

BELLUS Health Inc. (BLU)

Stock Price: $2.86 USD 0.13 (4.76%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $2.88 +0.02 (0.70%) Jul 29, 5:50 PM
Market Cap 215.04M
Revenue (ttm) 8,871
Net Income (ttm) -30.14M
Shares Out 78.34M
EPS (ttm) -0.58
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $2.86
Previous Close $2.73
Change ($) 0.13
Change (%) 4.76%
Day's Open 2.91
Day's Range 2.82 - 3.01
Day's Volume 1,469,753
52-Week Range 2.01 - 4.96

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

AJRD, BLU, GMBL, LITE, and PSXP have been added to the Zacks Rank #5 (Strong Sell) List on May 25, 2021

Other stocks mentioned: AJRD, GMBL, LITE, PSXP
2 months ago - Zacks Investment Research

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...

2 months ago - Business Wire

AFYA, BLU, CHRA, DHX, and EBMT have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2021

Other stocks mentioned: AFYA, CHRA, DHX, EBMT
2 months ago - Zacks Investment Research

Los Angeles, California--(Newsfile Corp. - May 17, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("BE...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 17, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September 5...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 16, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BELLU...

2 months ago - Newsfile Corp

TORONTO--(BUSINESS WIRE)--Morganti & Co., A pro-investor law firm with licensed and experienced lawyers in Canada and the United States that represent investors announces the filing of a securities clas...

2 months ago - Business Wire

New York, New York--(Newsfile Corp. - May 14, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased BELLUS Health Inc. ("...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 14, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BELLUS Health Inc. (NASDAQ: BLU) alleging tha...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 14, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September 5...

2 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - May 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("BE...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 14, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BELLU...

2 months ago - Newsfile Corp

LOS ANGELES--(BUSINESS WIRE)---- $BLU #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BELLUS Health Inc. (BLU)

2 months ago - Business Wire

Los Angeles, California--(Newsfile Corp. - May 13, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("BE...

2 months ago - Newsfile Corp

NEW YORK, May 13, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BELLUS Health Inc. ("BELLUS" or the "Company") (NASDAQ: BLU). Such investors are advised to contact...

2 months ago - PRNewsWire

NEW YORK, May 12, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action...

2 months ago - PRNewsWire

Los Angeles, California--(Newsfile Corp. - May 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("BE...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 12, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against BELLUS Health Inc. ("BELLUS" or "the Compan...

2 months ago - Newsfile Corp

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...

2 months ago - Business Wire

Bellus (BLU) delivered earnings and revenue surprises of -33.33% and -60.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...

2 months ago - Business Wire

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...

2 months ago - Business Wire

NEW YORK, May 5, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September 5, 2019 and July ...

2 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - April 30, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against BELLUS Health Inc. ("BELLUS" or "the Comp...

2 months ago - Newsfile Corp

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against BELLUS Health Inc. ("BELLUS" or "the Company") (...

3 months ago - Business Wire

New York, New York--(Newsfile Corp. - April 27, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September...

3 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 23, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September...

3 months ago - Newsfile Corp

NEW YORK, April 19, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class acti...

3 months ago - PRNewsWire

NEW YORK, April 16, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September 5, 2019 and Ju...

3 months ago - PRNewsWire

LOS ANGELES, April 16, 2021 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("BELLUS" or "the...

3 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - April 13, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BELLUS Health Inc. (NASDAQ: BLU) alleging t...

3 months ago - Newsfile Corp

LOS ANGELES, April 13, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired B...

3 months ago - PRNewsWire

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...

3 months ago - Business Wire

LOS ANGELES, April 12, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming  May 17, 2021 deadline to file a lead plaintiff motion in the class action filed on beha...

3 months ago - PRNewsWire

Los Angeles, California--(Newsfile Corp. - April 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("B...

3 months ago - Newsfile Corp

NEW YORK, April 6, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BELLUS Health Inc. ("BELLUS" or the "Company") (NASDAQ: BLU). Such investors are advised to contac...

3 months ago - PRNewsWire

LOS ANGELES, April 2, 2021 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("BELLUS" or "the ...

3 months ago - PRNewsWire

BENSALEM, Pa., April 2, 2021 /PRNewswire/ -- Law Offices of Howard G.

3 months ago - PRNewsWire

NEW YORK, April 2, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class actio...

3 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - April 1, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September ...

3 months ago - Newsfile Corp

NEW YORK, March 31, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September 5, 2019 and Ju...

3 months ago - PRNewsWire

SAN DIEGO & LAVAL, Quebec--(BUSINESS WIRE)---- $BLU #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of BELLUS Health Inc. (NASDAQ: BLU) filed a class action complaint ag...

3 months ago - Business Wire

Los Angeles, California--(Newsfile Corp. - March 30, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. ("...

3 months ago - Newsfile Corp

SAN DIEGO--(BUSINESS WIRE)-- #BELLUScase--The suit alleges defendants issued false statements concerning BELLUS business and prospects, resulting in its stock trading at inflated prices.

4 months ago - Business Wire

New York, New York--(Newsfile Corp. - March 24, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BELLUS Health Inc. (NASDAQ: BLU) alleging t...

4 months ago - Newsfile Corp

LOS ANGELES--(BUSINESS WIRE)---- $BLU #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 17, 2021 deadline to file a lead plaintiff motion in the class action filed ...

4 months ago - Business Wire

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...

4 months ago - Business Wire

New York, New York--(Newsfile Corp. - March 23, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of BELLUS Health Inc. .Shareholders...

4 months ago - Newsfile Corp

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BELLUS Health Inc. (NASDAQ: BLU) between September 5, 2019 and July 5, 2020, in...

4 months ago - Business Wire

New York, New York--(Newsfile Corp. - March 23, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased BELLUS Health Inc. ...

4 months ago - Newsfile Corp

About BLU

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.

Industry
Biotechnology
Founded
1993
CEO
Roberto Bellini
Employees
32
Stock Exchange
NASDAQ
Ticker Symbol
BLU
Full Company Profile

Financial Performance

In 2020, BELLUS Health's revenue was 15,000, a decrease of -44.44% compared to the previous year's 27,000. Losses were -31.76 million, 22.1% more than in 2019.

Financial numbers in millions CAD.
Financial Statements